AxCell Licenses ProChart Data to NCI for Prostate Cancer Research | GenomeWeb

NEW YORK, June 18 - AxCell Biosciences said today it will give the National Cancer Institute access to part of its ProChart database to help it research a prostate cancer-suppressor gene.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.